In 1999, Ramon et al. examined the effects of -aminolevulinic acid ( -ALA) on two cervical cancer cell lines (HeLa and CaLo) and normal cervical cells. The results reported additionally support the proposal that Photodynamic Therapy (PDT) could be an effective tool for treatment of cervical cancer (CeCa) by protoporphyrin IX (PpIX) accumulation. This cancer is in México considered a problem of public health.
Introduction
Photodynamic Therapy (PDT) has been approved by health agencies in several countries for treatment of neoplasias in several tissues, e.g., esophagus, lung and bladder, and for other pathologic conditions including actinic keratosis, atherosclerosis and age related macular degeneration [1] .
PDT is a promising treatment for cancer and other nonmalignant conditions, which involve the administration of a photosensitizing agent (usually a porphyrin-based compound), followed by exposure of the tissue to visible non-thermal light (400-760 nm). When the photosensitizer is illuminated with light of the appropriate wavelength, the molecule is excited. This produces a series of molecular energy transfer leading to the liberation of singlet oxygen, a highly reactive and cytotoxic species, resulting in cell death [2] .
One more recent and different concept under study involves the endogenous biosynthesis of porphyrin sensitizers subsequent to administration of -aminolevulinic acid ( -ALA), a precursor of the heme biosynthetic pathway, of which protoporphyrin IX (PpIX) is in the penultimate step [3] .
There have also been reports that PDT has been used in the treatment of patients with cervical cancer [4] . Owing to the fact that in México, cervical cancer is considered a public health problem, since 4,500 deaths annually in women between the ages of 20 and 65 years have been reported [5] ; it is considered to be, therefore, the principal cause of death among Mexican women.
We propose that PDT could be an effective tool for treatment of cervical cancer (CeCa), by the use of -aminolevulinic acid ( -ALA) as an inductor of PpIX since this photosensitizers accumulates in cervical cancer lines [6] . In this study we propose to develop a CeCa mouse model by implantation of HeLa cells in nu/nu mice, exposing it to -ALA to the dose that induces the greater concentration of PpIX by intratumoral and oral route, as well as the power and the number of optimal irradiations at 630 nm with a compact diode laser; verifying which of the used doses do not produce significant damage to the organs by means of histopatologic techniques: liver, spleen, brain and kidney, and in the same way the effect of residual -ALA. Finally, the size of the tumor at the beginning and at the end of the application of the PDT will be measured.
Materials and methods

Biological material
HeLa cells are a line derived from human epidermoid cervical cancer (ATCC). Female mice nu/nu (3-4 weeks) from Harlan USA.
Development of a mice cervical cancer model
In order to determine the adequate quantity of cells, 2 implants were made in 1 nu/nu mouse, in each leg with concentrations of, respectively 1 × 10 6 , 2 × 10 6 and 4 × 10 6 HeLa cells in 20 L of saline solution by intraepithelial route. It was determined the number of cells which produce a beginning the tumor, the time of development and duration of model without metastasis.
Selection of doses and route for exposure to
-aminolevulinic acid -aminolevulinic acid ( -ALA) was obtained in hydrochloride salt (98% pure) from Sigma Scientific, St. Louis, Mo, USA. It was dissolved in saline solution for concentrations of 5, 10, 20 and 40 mg -ALA/Kg body weight; they were administered by oral and intratumoral route to the two groups of 10 mice nu/nu each. The animals were killed after one hour of exposition to -ALA. Blood and tissues (liver, brain, kidney and tumor) were used to found the optimal accumulation of PpIX, tissue damage and residual -ALA.
Fluorometric procedure for the determination of protoporphyrin IX (PpIX)
The determination of PpIX concentration in tissue was carried out by means of Piomelli [7] spectrofluorometric assay for Free Erythrocyte Porphyrins (FEP) which was adapted for tissues. It was pipetted 40 l of blood or homogenised tissue, to the bottom of a small test tube containing 0.1 ml of a 5 percent celite suspension in saline, added 4 ml of a mixture of ethyl acetate/acetic acid (4 : 1), and agitated for 10 s on a vortex mixer, centrifuged during 30 s at 1500 rpm, the supernatant was separated in another test tube and added 4 ml of 1.5 N HCl, agitated during 10 s on a vortex mixer, finally with a Pasteur pipette was transferred and aliquot of the lower HCl phase into a cuvette, and reading the concentration of FEP directly in micrograms per 100 ml for blood, or micrograms per g of protein for the tissue. The spectrofluorometer (Perkin Elmer LS-2B) was calibrated with a standard solution of coproporphyrin I (0.05 mg/ml) from Sigma Scientific, St. Louis, Mo, USA.
Determination of -ALA in blood and tissue by HPLC
-ALA was determined by the method previously reported [8] . Briefly, 40 l of 25% trichloroacetic acid (TCA) and 10 l of 30 mM iodoacetamide were added to 100 l of blood, or homogenized tissue and vigorously agitated with a vortex mixture. After centrifugation at 3000 rpm for 10 min, 10 l of the supernatant was used for the derivatization. The standard reaction mixture for the derivatization contained 10 l of the supernatant, 240 l of distilled water, 250 l of 200 mM acetate buffer (pH 3.8), 1.25 ml of solution A (acetylacetone-ethanolwater 15 : 10 : 55 v/v/v), and 250 l of solution B (8.5% w/v formaldehyde solution.) The reaction was carried out at the boiling point for 15 min.After cooling, the mixture was used for the HPLC analysis.
A liquid chromatograph (Beckman Gold 128) with a fluorescence detector (Perkin Elmer LS-30) was used, the column (250 × 4.60 mm) was packed with reversed phase silica (Prodigy 5 ODS-3 Phenomenex). The mobile phase was methanolacetic acid-water 50 : 1 : 49 v/v/v. Flow rate, oven temperature, and detector wavelength were set at 1 ml/min, 40
• C, and 373 nm/463 nm (excitation/emission).
Measurement of Thiobarbituric Acid Reactive Substances
(TBARS) [9, 10] One gram of frozen tissue was mixed with 4 ml 0.05 M phosphates buffer (pH 7) and homogenized for 2 min using a motor driven tissue homogenizer. One milliliter was used for protein determination by the Lowry method [11] , using bovine albumin as a standard (Sigma, USA) and, one milliliter of the homogenates was immediately transferred to a 10 ml centrifuge tube containing 2.0 ml of thiobarbituric acid mix (0.5 g of thiobarbituric acid, 16 g of trichloroacetic acid and 2.5 ml of HCl, these reactives are dissolved in dH 2 O and the volume is made up to 100 ml) and freshly prepared. The tube was agitated for 30 s on a vortex mixer, boiling at 100
• C for 30 min, centrifuged during 10 min at 1500 rpm and 4
• C. The supernatant was separated in a cuvette. The resulting pink color was measured at 532 nm. TBARS were expressed as nmoles per milligram of protein.
Determination of tissue damage in the tumor and organs by
histology analysis Mice were sacrificed, immediately the organs were removed, fixed in 10% formalin for 24 hours and cut into 3 mm-thick transverse slices. The slices were routinely processed, embedded in paraffin, and serial sections, of 4-6 m thickness, were cut from it. The section were then stained with hematoxylin and eosin, and observed under a light microscope to find the incidence of damage [12] .
Photodynamic therapy application
Mice with a tumor were divided in the following groups: 4 mice for control (group for light exposure only), one group for each exposed group to -ALA, 4 mice for oral route of -ALA and treatment with 150 J/cm 2 3 times; 4 mice with the same -ALA and irradiation doses but 5 times; 4 mice for oral route of -ALA and treatment with 250 J/cm 2 3 times; 4 mice with the same -ALA and irradiation doses but 5 times. We work with a number of groups equal, but using the intratumoral route. The light exposure was: at 635 nm emitted from a diode laser (VISULAS 690s Zeizz), the fluence rate was 300 mW/cm 2 and each mouse received a total dose of 150 to 250 J/cm 2 , each 48 hours, a group was irradiated 5 and another 3 times as it was described before. During the light exposure, the mice were anesthetized with pentobarbital (80 mg/kg) for intrapheritoneal injection (Anestesal-Pfizaer México).
Size of tumors
The tumor volume was measured with an engineer's caliper and was calculated with the following formula [13] :
Statistical analysis
Data are presented as mean ± standard error. Analysis was performed by one-way analysis of variance (ANOVA) and the significance of the differences between the groups was tested with the tukey test. The level of significance was accepted at p ≤ 0.05.
Results
Development of a mice cervical cancer model
The cervical cancer mouse model is developed by implantation of 1.5 million HeLa cells, appearing at 15 days after the implantation without metastasis.
Protoporphyrin IX, residual -ALA, TBARS Measurement and Histology
In the control groups (mice not treated with -ALA) small amounts of endogenous PpIX were found in blood: PpIX by oral route was 54.34 g FEP/100 ml blood and PpIX by intratumoral route was 2.33 g FEP/100 ml blood and in the tumor: PpIX for oral route was 9.5 × 10 −4 g FEP/mg of protein and intratumoral route PpIX was 3.5 x 10 −3 g FEP/mg of protein ( figure 1 and  table I ).
It was found that the dose of -ALA that induces the greater concentration of PpIX in the blood (366.571 g FEP/100 ml blood) after 1 h of intratumoral administration was 40 mg of -ALA/Kg body weight, and we found a PpIX concentration in the tumor statistically significant (8.4 × 10 −3 g FEP/mg of protein), and the dose of -ALA that induces the greater concentration of PpIX in the blood (12.95 g FEP/100 ml blood) after 1h of oral administration, was 20 mg of -ALA/kg body weight, and we also find a PpIX concentration in tumor significant (2.7 × 10 −3 g FEP/mg of protein), both routes did not present significant damage in the brain and spleen, according to light microscopic examination of biopsies, although these doses induce significant residual -ALA (p < 0.05), the -ALA was unable to produce lipoperoxidation (TBARS was p > 0.05) for both routes. A statistically significant difference (p < 0.05) was found in TBARS in the liver and kidney when the animals were exposed to 40 mg of -ALA/Kg by intratumoral route and 20 mg of -ALA/kg body weight by oral route, in these doses the residual -ALA is able to induce lipoperoxidation (table II) and it causes damage because we could see small isolated areas (focal) of necrosis in both organs.
Effectiveness of -ALA-based PDT in tumors: size and
histopathology Having established that the tumors accumulate PpIX after administration of -ALA by intratumoral or oral route, we next determined the effects of PDT on the tumors by volume quantification and histopathological examination of the tumors, and the surrounding normal tissue. The initial mean tumor size in both control and treatment mice were similar. The greater diminution in the size of the tumor (53%) was ten days after the first treatment, by the oral route and treatment to a power of 150 J/cm 2 with 5 irradiations in intervals of 48 h (table III) . It was confirmed the diminution of tumor volume with the histologic study with the presence of severe necrosis (90%). In the control group (group without -ALA and with irradiation), the tumours doubled three times in size during the 5 irradiations, the tumour shows muscle invasion, which is typical of established tumours however we could determine a high necrosis percentage (72%). The PDT using the -ALA by intratumoral route did not show decrease in the tumour volume, however the tumours did not invade muscle and we observed a high level of tumoral necrosis (from 60 to 80%).
Discussion
The cervical cancer mouse model is developed by implantation of 1.5 million HeLa cells appearing at 15 days after the implant without metastasis, this number of cells is comparable with the reported [14] , which used 5 × 10 5 and 5 × 10 7 cells. The -ALA doses used in this PDT experiment were safe for the brain, this determination was made because, it has been reported that the brain is considered to be at particular risk for free radical damage and the -ALA toxicity may relate to the generation of free radicals during its autoxidation [15] [16] [17] .
Focal light necrosis was found in the liver and kidney. We think it could be reversible because the liver is a major biosynthesis site for porphyrin and heme production, as well as their metabolic degradation. This was already previously demonstrated by Hua et al. in 1995 [18] , and the kidney is the elimination organ.
The greater diminution in the tumor volume (53%) was ten days after the first treatment, by the oral route to a power of 150 J/cm 2 with 5 irradiations in intervals of 48 h (table III) , it is comparable with other in vivo studies where they utilized similar doses and irradiated in different types of cancer, and found the existence of a significant diminution in the tumour volume (50%) [19] . It was confirmed the diminution of tumour volume with the histologic study with the presence of severe necrosis showed by the tumor (90%). These results are better than those from other studies, which utilize other photosensitizers with an average 62% of necrosis in cancer of esophagus, 74% of papillares lesions of genitourinary system [20] .
The tumoral necrosis found in the mice control, might be explain by the presence of endogenous PpIX. These effects have been observed in other tumours e.g. our own experience with melanoma tumour (results not published) and results reported by Juzena et al. in 2002 [21] .
Conclusions
Our data support the conclusion that PpIX is efficiently formed in cervical cancer after oral administration of ALA and the doses used are safe. The tumoral necrosis induced by the PDT shows that this therapy is a promising treatment for cervical cancer, but further studies are needed to eliminate this cancer type totally.
